InsidersTradesSigma
Follow the 현대약품 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 현대약품 has published 1 reports. Market capitalisation: €163.5bn. The latest transaction was filed on 4 March 2026 (Purchase). Among the most active insiders: 신풍제약. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hyundai Pharmaceutical 是一家韩国公司，专注于医疗保健和制药领域。该公司在 XKRX 上市。